TBPH
Theravance Biopharma Inc · Healthcare · Biotechnology
Input momentum (manajer yang sebanding): keluasan pemegang 0.0% · aliran saham +8.0% · posisi baru bersih 0.0% — formula
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 78 | 0 | 20.06M | $340.93M | +5 | −5 |
| Q1 2026 | 81 | 0 | 20.48M | $332.45M | +7 | −7 |
| Q4 2025 | 81 | +1 | 20.44M | $382.41M | +1 | — |
| Q3 2025 | 17 | 0 | 12.34M | $180.13M | +1 | −1 |
| Q2 2025 | 14 | +1 | 10.14M | $111.79M | +2 | −1 |
| Q1 2025 | 10 | +2 | 4.07M | $36.36M | +2 | — |
| Q4 2024 | 8 | 0 | 3.76M | $35.35M | — | — |
| Q3 2024 | 7 | -2 | 2.37M | $19.08M | — | −2 |
| Q2 2024 | 9 | — | 6.87M | $58.23M | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasif) | 4.07M | -1.7% | $59.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | BlackRock ✦ (pasif) | 4.07M | -1.7% | $59.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | BlackRock ✦ (pasif) | 4.07M | -1.7% | $59.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | BlackRock ✦ (pasif) | 4.07M | -1.7% | $59.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | BlackRock ✦ (pasif) | 4.07M | -1.7% | $59.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (pasif) | 4.07M | -1.7% | $59.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (pasif) | 4.07M | -1.7% | $59.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (pasif) | 4.07M | -1.7% | $59.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (pasif) | 4.07M | -1.7% | $59.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | BlackRock ✦ (pasif) | 4.07M | -1.7% | $59.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | BlackRock ✦ (pasif) | 4.07M | -1.7% | $59.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | The Vanguard Group ✦ (pasif) | 2.21M | +2.5% | $32.29M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | The Vanguard Group ✦ (pasif) | 2.21M | +2.5% | $32.29M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | The Vanguard Group ✦ (pasif) | 2.21M | +2.5% | $32.29M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 1.21M | +20.7% | $17.66M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 1.21M | +20.7% | $17.66M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 17 | State Street Global Advisors ✦ (pasif) | 1.06M | +2.0% | $15.42M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | Geode Capital Management ✦ (pasif) | 897.99K | +0.5% | $13.11M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 19 | Geode Capital Management ✦ (pasif) | 897.99K | +0.5% | $13.11M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 20 | Arrowstreet Capital ✦ | 726.78K | Baru | $10.61M | 0.0% | New | 1 | SEC ↗ |
| 21 | Morgan Stanley ✦ | 599.55K | — | $8.75M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Morgan Stanley ✦ | 599.55K | — | $8.75M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Morgan Stanley ✦ | 599.55K | — | $8.75M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Morgan Stanley ✦ | 599.55K | — | $8.75M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Morgan Stanley ✦ | 599.55K | — | $8.75M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Morgan Stanley ✦ | 599.55K | — | $8.75M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Morgan Stanley ✦ | 599.55K | — | $8.75M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Morgan Stanley ✦ | 599.55K | — | $8.75M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | JPMorgan Chase ✦ | 426.21K | — | $6.22M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | JPMorgan Chase ✦ | 426.21K | — | $6.22M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | JPMorgan Chase ✦ | 426.21K | — | $6.22M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | JPMorgan Chase ✦ | 426.21K | — | $6.22M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 426.21K | — | $6.22M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | JPMorgan Chase ✦ | 426.21K | — | $6.22M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | JPMorgan Chase ✦ | 426.21K | — | $6.22M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | JPMorgan Chase ✦ | 426.21K | — | $6.22M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | JPMorgan Chase ✦ | 426.21K | — | $6.22M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | JPMorgan Chase ✦ | 426.21K | — | $6.22M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 426.21K | — | $6.22M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 426.21K | — | $6.22M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | Marshall Wace ✦ | 357.65K | +254.9% | $5.22M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 42 | Goldman Sachs Group ✦ | 258.65K | — | $3.78M | 0.0% | n/c | 1 | SEC ↗ |
| 43 | Goldman Sachs Group ✦ | 258.65K | — | $3.78M | 0.0% | n/c | 1 | SEC ↗ |
| 44 | Two Sigma Investments ✦ | 231.27K | +1199.9% | $3.38M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 45 | Wellington Management ✦ | 130.15K | -22.3% | $1.90M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 46 | Wellington Management ✦ | 130.15K | -22.3% | $1.90M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 47 | Wellington Management ✦ | 130.15K | -22.3% | $1.90M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 48 | T. Rowe Price ✦ | 64.14K | +2.7% | $937,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 49 | Citadel Advisors ✦ | 50.87K | -89.5% | $742,659 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 50 | Citadel Advisors ✦ | 50.87K | -89.5% | $742,659 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 51 | Millennium Management ✦ | 24.49K | -44.1% | $357,583 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 52 | AQR Capital Management ✦ | 18.84K | +53.8% | $274,990 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 53 | AQR Capital Management ✦ | 18.84K | +53.8% | $274,990 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 54 | AQR Capital Management ✦ | 18.84K | +53.8% | $274,990 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 55 | AQR Capital Management ✦ | 18.84K | +53.8% | $274,990 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 56 | AQR Capital Management ✦ | 18.84K | +53.8% | $274,990 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 57 | Fidelity (FMR) ✦ | 4.72K | -4.0% | $68,897 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 58 | Fidelity (FMR) ✦ | 4.72K | -4.0% | $68,897 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Arrowstreet Capital | $10.61M | 0.0% |
Telah keluar
| Point72 Asset Management | $139,991 | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 170 pemegang, 49.68M saham, $776.87M dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.